 Emkay Global Financial Services Ltd consolidated Q2 FY2026 PAT slumps to Rs. 45.95 lakhs
Emkay Global Financial Services Ltd consolidated Q2 FY2026 PAT slumps to Rs. 45.95 lakhs Dhanuka Agritech Ltd Q2 FY2026 PAT at Rs. 93.96 crores
Dhanuka Agritech Ltd Q2 FY2026 PAT at Rs. 93.96 crores Divyashakti Ltd Q2 FY26 loss at Rs. 8.34 lakhs
Divyashakti Ltd Q2 FY26 loss at Rs. 8.34 lakhs Mphasis Ltd Q2FY26 consolidated net profit up at Rs. 469.07 crores
Mphasis Ltd Q2FY26 consolidated net profit up at Rs. 469.07 crores True Colors Ltd repays its entire outstanding term loan
True Colors Ltd repays its entire outstanding term loan 
              Kwality Pharmaceuticals Ltd has received the approval (inspection from 8th July to 16th July, 2024) from the General Directorate of Medicines, Supplies and Drugs (DIGEMID), PERU for its Generic, Injectable & OSD (Unit-1 in Amritsar)
Kwality Pharma already has registration of 20 molecules from above units and 20 are under registration. These registrations includes 4-peptide based injectable suspension.
This certification will allow Kwality Pharma to participate in Government and Private Market.
Shares of Kwality Pharmaceuticals Ltd was last trading in BSE at Rs. 497.40 as compared to the previous close of Rs. 494.05. The total number of shares traded during the day was 3462 in over 93 trades.
The stock hit an intraday high of Rs. 498.95 and intraday low of 494.00. The net turnover during the day was Rs. 1718441.00.